Nirmatrelvir

規格

2628280-40-8CAS番号

881-018-3EC番号

(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamideIUPAC名

C23H32F3N5O4化学式

499.5 g/mol分子量

Nirmatrelvir; 2628280-40-8; PF-07321332; Paxlovid; PF07321332; 7R9A5P7H32; PF 07321332; CHEBI:170007; DTXSID501336829; PAXLOVID COMPONENT NIRMATRELVIR; (1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-6,6-dimethyl-3-(3-methyl-N-(trifluoroacetyl)-L-valyl)-3-azabicyclo(3.1.0)hexane-2-carboxamide; (1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; (1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide; (1R,2S,5S)-N-((1S)-1-cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide; (1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; RefChem:53396; DTXCID901767123; SARS-CoV-2 3CLpro Inhibitor PF-07321332; SARS-CoV-2-3CL Protease Inhibitor PF-07321332; Nirmatrelvir [USAN]; (1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; GTPL11503; (1R,2S,5S)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-; C23H32F3N5O4; Paxlovid-d9; (1R,2S,5S)-N-[(S)-1-Cyano-2-[(S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; 3-Azabicyclo(3.1.0)hexane-2-carboxamide, N-((1S)-1-cyano-2-((3S)-2-oxo-3-pyrrolidinyl)ethyl)-3-((2S)-3,3-dimethyl-1-oxo-2-((2,2,2-trifluoroacetyl)amino)butyl)-6,6-dimethyl-, (1R,2S,5S)-; MFCD34473213; Boceprevir Impurity 5; Nirmatrelvir (Standard); science.abl4784, 6; Nirmatrelvir (JAN/USAN); NIRMATRELVIR [INN]; NIRMATRELVIR [JAN]; Paxlovid (active component); NIRMATRELVIR [WHO-DD]; UNII-7R9A5P7H32; PF07321332(nirmatrelvir); orb1298161; CHEMBL4802135; SCHEMBL24108848; Pf-07321332; Nirmatrelvir; PF07321332(nirmatrelvir)?; BDBM496902; GLXC-23977; EX-A5024; MSK168892D9; Paxlovid (nirmatrelvir + ritonavir); MSK168892; WHO 12161; 2628280-40-8 (Unlabelled); AT31194; EBC-145089; HY-138687R; NCGC00846193-01; AC-35259; SY295161; example E61 [WO2021250648A1]; DB-387718; HY-138687; 870124 More info PF-00835231; CS-0166635; T9351; D12244; EN300-28333908; P200002; Z4994097664; Nirmatrelvir; PF-07321332; PF 07321332; PF07321332; brand name Paxlovid; (1S,3aS,4aR)-N-[(1S)-1-cyano-2-[(3S)-2-oxotetrahydro-1H-pyrrol-3-yl]ethyl]-2-[(2S)-3,3-dimethyl-1-oxo-2-[(trifluoroacetyl)amino]butyl]-4,4-dimethyl-2,3,3a,4a-tetrahydro-1H-cyclopropa[1,2-c]pyrrole-1-carboxamide; ZGW別名